Saylor Defends Microstrategy Equity Sales as Accretive
Michael Saylor told a BTC Prague panel on Friday that microstrategy’s equity issuances are “massively accretive” when liabilities and asset purchases are included in the math. The Strategy executive chairman was responding to dilution criticism that has followed the company’s Bitcoin financing model and its mNAV framework.
“The idea that selling equity is dilutive is a misnomer,” Saylor said during the digital credit strategy panel on June 14, 2026. For shareholders, his argument rests on whether new capital buys assets or cash flows that outweigh the shares issued.
BTC Prague and mNAV
Saylor said Strategy’s mNAV metric combines stock market capitalization, net debt and “nominal” preferred share capital. He also said the company’s 8-K and 10-Q filings carry disclaimers that mNAV “doesn’t show the full financial picture,” and he urged investors to weigh multiple metrics before making financial decisions.
1 billion dollars of equity issued to create a 1.1 billion dollar capital structure, in Saylor’s framework, does not dilute shareholders. He drew a line between that kind of transaction and overpaying for an intangible asset that later gets written down, which he said could amount to dilution.
Jack Mallers Pushes Back
Jack Mallers, the CEO of Twenty One Capital, challenged Saylor on whether treating out-of-the-money convertible securities as equity inflates the mNAV calculation. He said Alphabet’s recent preferred and common stock issuances had been characterized as dilutive, and added that if he raised 100 grand for 10 percent of a company, he would treat that as dilution.
100 million of equity can still be a poor trade if the proceeds go into assets that do not earn enough to offset the cost, Saylor said. He used semiconductors and Nvidia chips with a useful life of four years as his example of a case that would probably be dilutive unless the business generates offsetting cash flows.
Preferred Equity and Liquidation
Strategy’s Short Duration High Yield Credit Stretch preferred equity instruments only become liabilities in liquidation, Saylor said, adding that liquidation of those instruments is impossible absent maturing debt. That leaves investors with two different readings of the same balance sheet: one based on share count, the other on the net value of what the capital bought.
“These business models are embryonic in their first year. I don’t think there’s a single metric,” Saylor said. For readers trying to decide how to treat microstrategy’s issuance strategy, the dispute now turns on which metric they trust first: share dilution, mNAV, or the assets financed with the proceeds.
